No connection

Search Results

EQBK

NEUTRAL
$45.34 Live
Equity Bancshares, Inc. · NYSE
Target $51.6 (+13.8%)
$36.04 52W Range $50.07

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
$941.58M
P/E
38.42
ROE
3.4%
Profit margin
11.2%
Debt/Equity
N/A
Dividend yield
1.59%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
EQBK presents a stark contrast between fundamental health and market expectations. The deterministic health baseline is weak, highlighted by a Piotroski F-Score of 2/9, indicating significant deterioration in financial strength. While the stock trades at a substantial premium to its Graham Number ($32.33) and Intrinsic Value ($8.26), it is supported by a consistent track record of earnings beats and strong revenue growth (33% YoY). The massive discrepancy between the current P/E (38.42) and Forward P/E (8.61) suggests the market is pricing in a major earnings recovery that has yet to fully materialize in the ROE (3.44%).

Key Strengths

Consistent earnings beat track record over 25 quarters
Strong top-line revenue growth (33% YoY)
Low Forward P/E (8.61) suggesting high future earnings potential
Positive analyst sentiment with a target price of $51.60
Reasonable Price-to-Book ratio (1.15) for the banking sector

Key Risks

Critically low Piotroski F-Score (2/9) indicating poor financial health
Very low ROE (3.44%) and ROA (0.38%) compared to industry standards
Significant overvaluation relative to intrinsic value ($8.26) and Graham number ($32.33)
Bearish technical trend (0/100) and bearish insider selling
Negative year-over-year earnings growth (-5.9%)
AI Fair Value Estimate
Based on comprehensive analysis
$33.5
-26.1% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
49
Moderate
Value
30
Future
65
Past
85
Health
15
Dividend
50
AI Verdict
Speculative Hold
Key drivers: Piotroski F-Score, Forward P/E, Revenue Growth, Earnings Beat History
Confidence
80%
Value
30/100

Ref P/E 38.42, Graham Number $32.33

Positives
  • P/B ratio is near 1.0
Watchpoints
  • Price is 40% above Graham Number
  • Price is 450% above Intrinsic Value
  • High trailing P/E
Future
65/100

Ref Growth rates and Forward P/E

Positives
  • 33% YoY Revenue growth
  • Strong Forward P/E compression
  • Positive Q/Q earnings growth
Watchpoints
  • Negative YoY earnings growth
Past
85/100

Ref Historical earnings surprises

Positives
  • Exceptional record of beating estimates (3/4 last 4, consistent over 25 quarters)
  • Strong 3Y and 5Y price appreciation
Watchpoints
No urgent risks highlighted.
Health
15/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 2/9 is critically weak
  • Anemic ROE and ROA
Dividend
50/100

Ref Yield and Payout

Positives
  • Sustainable payout ratio (58.47%)
Watchpoints
  • Low yield (1.59%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$45.34
Analyst Target
$51.6
Upside/Downside
+13.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for EQBK and closest competitors.

Updated 2026-04-24
EQB
Equity Bancshares, Inc.
Primary
5Y
+61.2%
3Y
+107.2%
1Y
+19.4%
6M
+9.2%
1M
+4.2%
1W
-1.4%
ASI
Ategrity Specialty Insurance Company Holdings
Peer
5Y
-21.6%
3Y
-21.6%
1Y
-21.6%
6M
-5.8%
1M
+13.2%
1W
-2.0%
AMT
Amerant Bancorp Inc.
Peer
5Y
+35.7%
3Y
+32.5%
1Y
+37.3%
6M
+31.1%
1M
+5.5%
1W
-4.2%
BFS
Business First Bancshares, Inc.
Peer
5Y
+34.8%
3Y
+98.0%
1Y
+22.3%
6M
+14.3%
1M
+5.5%
1W
-2.5%
BBD
Barings BDC, Inc.
Peer
5Y
+71.2%
3Y
+50.1%
1Y
+5.0%
6M
+1.6%
1M
+3.4%
1W
-0.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
38.42
Forward P/E
8.61
PEG Ratio
1.69
P/B Ratio
1.15
P/S Ratio
4.27
EV/Revenue
3.91
EV/EBITDA
N/A
Market Cap
$941.58M

Profitability

Profit margins and return metrics

Profit Margin 11.19%
Operating Margin 39.82%
Gross Margin N/A
ROE 3.44%
ROA 0.38%

Growth

Revenue and earnings growth rates

Revenue Growth +33.0%
Earnings Growth -5.9%
Q/Q Revenue Growth +25.61%
Q/Q Earnings Growth +12.8%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$27.21

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-13
$N/A
2026-04-14
$1.24
+6.6% surprise
2026-01-21
$1.2
+6.4% surprise
2025-10-14
$1.16
+17.4% surprise

Financial Services Sector Comparison

Comparing EQBK against 763 companies in the Financial Services sector (133 bullish, 317 neutral, 313 bearish)
P/E Ratio
38.42
This Stock
vs
38.21
Sector Avg
+0.5% (Premium)
Return on Equity (ROE)
3.44%
This Stock
vs
-1.82%
Sector Avg
-288.7% (Below Avg)
Profit Margin
11.19%
This Stock
vs
75.74%
Sector Avg
-85.2% (Weaker)
Revenue Growth
33.0%
This Stock
vs
37.18%
Sector Avg
-11.2% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KNUTSON ANN
Officer
Sell
2026-03-19
450 shares · $19,768
HUBER JULIE A.
Chief Operating Officer
Stock Award
2026-02-25
1,302 shares
HUBER JULIE A.
Chief Operating Officer
Stock Award
2026-02-25
1,165 shares
ELLIOTT BRAD S.
Chief Executive Officer
Stock Award
2026-02-25
4,295 shares
ELLIOTT BRAD S.
Chief Executive Officer
Stock Award
2026-02-25
3,848 shares
REBER BRETT A
General Counsel
Stock Award
2026-02-25
1,259 shares
REBER BRETT A
General Counsel
Stock Award
2026-02-25
1,127 shares
NAVRATIL CHRIS M
Chief Financial Officer
Stock Award
2026-02-25
547 shares
NAVRATIL CHRIS M
Chief Financial Officer
Stock Award
2026-02-25
489 shares
SEMS RICHARD M
Officer
Buy
2026-02-23
110 shares · $4,964
KOSSOVER GREGORY H.
Officer and Director
Stock Award
2026-02-09
4,212 shares
KOSSOVER GREGORY H.
Officer and Director
Stock Award
2026-02-09
3,370 shares
PASS DAVID E. JR
Chief Technology Officer
Stock Award
2026-02-06
1,844 shares
HUBER JULIE A.
Chief Operating Officer
Stock Award
2026-02-06
4,504 shares
ELLIOTT BRAD S.
Chief Executive Officer
Stock Award
2026-02-06
14,822 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-22

EQBK filed an 8-K on April 22, 2026, likely to announce its first-quarter financial results.

8-K
8-K
2026-04-14

Equitable Bank (EQBK) likely filed this 8-K to announce its first-quarter financial results for 2026.

8-K/A
8-K/A
2026-03-18

Equity Bank Holding Company filed an amendment to a previously submitted current report on March 18, 2026.

DEF 14A
DEF 14A
2026-03-12

EQBK filed a definitive proxy statement on March 12, 2026, providing shareholders with necessary information to vote at the company's annual meeting.

10-K
10-K
2026-03-06

EQBK filed its annual 10-K report on March 6, 2026. The provided excerpts do not contain specific financial metrics or detailed risk disclosures, limiting the available analysis of the company's financial performance and risk profile.

8-K
8-K
2026-02-23

EQBK filed an 8-K on February 23, 2026, likely to announce its financial results for the preceding period.

8-K
8-K
2026-02-17

EQBK filed an 8-K on February 17, 2026, likely to announce its annual financial results for the preceding fiscal year.

8-K
8-K
2026-01-22

EQBK likely reported its fourth quarter and full-year financial results for the fiscal year ended December 31, 2025.

8-K
8-K
2026-01-21

EQBK filed an 8-K on January 21, 2026, likely to announce its fourth-quarter and full-year financial results.

8-K
8-K
2026-01-02

Equitable Bank filed an 8-K on January 2, 2026, likely reporting year-end financial results or corporate governance updates effective January 1.

8-K
8-K
2025-12-11
8-K
8-K
2025-11-05
10-Q
10-Q
2025-11-03
8-K
8-K
2025-10-14
8-K
8-K
2025-09-26
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
5 analysts
Piper Sandler
2026-04-16
Maintains
Overweight Overweight
DA Davidson
2026-04-16
Maintains
Neutral Neutral
DA Davidson
2026-01-23
Maintains
Neutral Neutral
Keefe, Bruyette & Woods
2026-01-23
Maintains
Market Perform Market Perform
Piper Sandler
2026-01-12
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning EQBK from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile